KGF:LSEKingfisher Plc Analysis
Data as of 2026-05-27 - not real-time
£298.00
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Kingfisher plc trades at 298 p, comfortably above its 20‑day (285.9 p) and 50‑day (292.3 p) moving averages but still below the 200‑day SMA (303.1 p), indicating a short‑term technical edge within a longer‑term bearish backdrop. The RSI sits at 56, suggesting neither overbought nor oversold conditions, while the MACD histogram is positive, giving the indicator a bullish tilt despite a negative MACD line. Valuation metrics are mixed: a forward P/E of 10.6 and a price‑to‑book of 0.82 point to a potentially fair or slightly undervalued position, yet the DCF‑derived fair value of ~705 p implies a sizeable gap that the model’s modest 5.6 % upside estimate tempers. The company delivers a generous dividend yield of 4.17 % but a payout ratio near 90 % raises questions about sustainability, especially given thin operating margins (3.9 %) and modest revenue growth (1.8 %). Volatility is elevated at 28.9 % over the past 30 days, though beta is low (~0.5), indicating limited market‑wide risk exposure. Analyst consensus is neutral (hold) with median target price of 305.5 p, offering limited upside of roughly 5‑6 % from current levels.
Overall, the stock presents a value‑oriented case supported by a solid balance sheet, strong cash flow, and attractive yield, but short‑term price pressure and dividend sustainability concerns suggest a cautious stance. Investors seeking income and long‑term recovery potential may consider buying on dips, while those focused on immediate price appreciation should remain on the sidelines or hold.
Overall, the stock presents a value‑oriented case supported by a solid balance sheet, strong cash flow, and attractive yield, but short‑term price pressure and dividend sustainability concerns suggest a cautious stance. Investors seeking income and long‑term recovery potential may consider buying on dips, while those focused on immediate price appreciation should remain on the sidelines or hold.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Bearish longer‑term trend (price below 200‑day SMA)
- High dividend yield with sustainability concerns
- Limited short‑term upside per analyst targets
Medium Term
1–3 yearsNeutral
Model confidence: 7/10
Key Factors
- Fair valuation (forward P/E 10.6, P/B 0.82)
- Modest upside potential (~5‑6 %)
- Strong cash flow supporting dividend continuity
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- Undervalued relative to book value
- Low beta indicating defensive characteristics
- Attractive dividend yield for income‑focused investors
Key Metrics & Analysis
Financial Health
Revenue Growth1.80%
Profit Margin1.89%
P/E Ratio21.3
ROE3.92%
ROA3.65%
Debt/Equity38.02
P/B Ratio0.8
Op. Cash Flow£1.4B
Free Cash Flow£972.4M
Technical Analysis
TrendBearish
RSI56.5
Support£270.00
Resistance£316.45
MA 20£285.93
MA 50£292.28
MA 200£303.09
MACDBullish
VolumeIncreasing
Fear & Greed Index91.29
Valuation
Fair Value£704.93
Target Price£314.56
Upside/Downside5.56%
GradeFair
TypeValue
Dividend Yield4.17%
Risk Assessment
Beta0.49
Volatility28.91%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.